Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Journal of Biopharmaceutical Statistics|September 22, 2007
Analysis of treatment effectiveness in longitudinal observational dataDouglas Faries, Haya Ascher-Svanum, Mark Belger
Archives of Cardiovascular Diseases|March 16, 2011
A prospective observational study of treatment practice patterns in acute coronary syndrome patients undergoing percutaneous coronary intervention in EuropeJean Ferrières, Magali Sartral, Stéphanie Tcherny-Lessenot, et al.
The Journal of Sexual Medicine|October 17, 2009
Effects of 12-month tadalafil therapy for erectile dysfunction on couple relationships: results from the DETECT studyBenny Verheyden, Thierry Roumeguère, Alain Bitton, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 18, 2006
Antipsychotic type and correlates of antipsychotic treatment discontinuation in the outpatient treatment of schizophreniaJosep Maria Haro, Diego Novick, Mark Belger, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 22, 2019
Alternative Weighting Approaches for Anchored Matching-Adjusted Indirect Comparisons via a Common ComparatorHelmut Petto, Zbigniew Kadziola, Alan Brnabic, et al.
Journal of Alzheimer'S Disease : JAD|May 21, 2014
Systematic literature review and meta-analysis of diagnostic test accuracy in Alzheimer's disease and other dementia using autopsy as standard of truthSandrine Cure, Keith Abrams, Mark Belger, et al.
Pragmatic and Observational Research|January 23, 2015
Understanding the treatment of attention deficit hyperactivity disorder in newly diagnosed adult patients in general practice: a UK database studyChristopher Bushe, Bernard Wilson, Foula Televantou, et al.
The Journal of Headache and Pain|July 5, 2022
Relative efficacy of lasmiditan versus rimegepant and ubrogepant as acute treatments for migraine: network meta-analysis findingsPepa Polavieja, Mark Belger, Shiva Kumar Venkata, et al.
Diabetes, Obesity & Metabolism|January 19, 2023
Long-term cost-effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the United StatesWilliam J Valentine, Meredith Hoog, Reema Mody, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 21, 2014
Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trialsKristin Kahle-Wrobleski, Howard Fillit, Jonathan Kurlander, et al.
Pageof 7